/
/
/

Lasa Supergenerics Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Empty box

No results found

Share Market Cap & Key Ratios Overview

Empty box

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Empty box

No results found

Key Highlights of Lasa Supergenerics Ltd’s P&L

In 2024-03-31, Lasa Supergenerics Ltd reported total revenue of ₹104.33Cr, compared with ₹129.57Cr in 2023-03-31, reflecting Lasa Supergenerics Ltd turnover.

Depreciation was ₹10.67Cr and finance costs were ₹1.99Cr in 2024-03-31

Profit Before Tax (PBT) has been ₹-₹19.11Cr in 2024-03-31 as compared to ₹-₹42.27Cr in 2023-03-31.

Net Profit (PAT) was ₹-₹21.73Cr in 2024-03-31 compared with ₹-₹38.62Cr in 2023-03-31.

Earnings per share (EPS) were ₹-4.34 in 2024-03-31, compared with ₹-7.71 in 2023-03-31.